Enter your login e-mail to the account
Search
Search parameters
Search results
- Chronic venous disease and cardiovascular disease
Doc. MUDr. Debora Karetová, CSc., prof. MUDr. Jan Bultas, CSc.
(3/2023, Review articles ) - Risk factors of atherosclerosis: lipids and their relation to atherosclerosis
MUDr. Branislav Vohnout, PhD., doc. MUDr. Katarína Rašlová, CSc.
(3/2009, Topic of the year ) - Vinpocetine and its clinical implication in the current psychiatric practise
Mgr. MUDr. Jozef Dragašek, PhD., MHA, MUDr. Zuzana Vančová, PhD.
(6/2021, Interdisciplinary consilium ) - MANAGEMENT OF ATHEROGENIC DYSLIPIDAEMIA IN THE METABOLIC SYNDROME
MUDr. Ľubomíra Fábryová
(S4/2007, Supplement ) - NEW ASPECTS OF PREVENTION AND THERAPY OF OSTEOPOROSIS
prof. MUDr. Juraj Payer, CSc., MUDr. Zdenko Killinger, PhD., MUDr. Lahim Baqi, MUDr. Patrícia Hrúziková
(11/2005, Topic ) - PREVENTION OF OBESITY
MUDr. Ivan Majerčák
(12/2005, Topic ) - Arterial hypertension in adolescents
prof. MUDr. Ľudovít Gašpar, CSc., prof. MUDr. Ján Murín, CSc.
(3/2020, Review articles ) - Hypertension in Metabolic Syndrome and Cardiovascular Risk
MUDr. Ivan Majerčák
(6/2006, clearly ) - Systemic consequences of chronic obstructive pulmonary disease and comorbidities
MUDr. Bohumil Matula
(9/2009, Review articles ) - Management and treatment of patient with schizophrenia
MUDr. Branislav Moťovský
(4/2010, Interdisciplinary consilium ) - NOVEL INSULINS – ANALOGS IN TYPE 2 DM TREATMENT
doc. MUDr. Emil Martinka, PhD.
(7-8/2008, Topic ) - OBESITY AND TYPE 2 DIABETES (DIABESITY) – TWO CLOSELY RELATED, PREVENTABLE DISEASES IS THE THERAPY OF OBESITY TOOL FOR PREVENTION OF METABOLIC SYNDROME AND TYPE 2 DIABETES?
MUDr. Ľubomíra Fábryová
(12/2006, Topic ) - Classification of dyslipoproteinaemias: Part I – Primary dyslipoproteinaemias
MUDr. Ľubomíra Fábryová, PhD.
(5/2009, Topic of the year )
- The effect of antidepressants on serum lipid parameters
MUDr. Dagmar Breznoščáková, Mgr. Martina Chylová, PhD., Klára Maceková
(4/2011, Original articles & case reports ) - Treatment with atypical antipsychotic drugs and their selection based on the spectrum of side effects
doc. MUDr. Radovan Přikryl, Ph.D.
(1/2009, Review articles ) - Practical aspects and several new horizons for the use of ziprasidone
MUDr. Michal Patarák
(3/2013, Psychopharmacology ) - Vinpocetine and its clinical implication in the current psychiatric practise
Mgr. MUDr. Jozef Dragašek, PhD., MHA, MUDr. Zuzana Vančová, PhD.
(3/2021, Review articles ) - Psychological profile of a morbidly obese patient interested in metabolic-bariatric surgery, case studies
MUDr. Kamila Ivanová
(4/2021, Case reports ) - Aripiprazole in the form of long-acting intramuscular injections in the clinical practice
prof. MUDr. Jiří Masopust, Ph.D.
(1/2022, PSYCHOPHARMACOLOGY ) - Omega-3 and details of their mechanism of action in relation to cytokines and markers of inflammation in affective disorders
MUDr. Hedvika Ernsten
(3/2023, Review articles ) - Ziprasidone treatment and metabolic parameters changes
MUDr. Jozef Dragašek, PhD., MUDr. Simona Líšková
(2/2011, Original articles & case reports ) - Treatment of farmacoresistant depression in polymorbid patient
MUDr. Jana Komorousová, Ph.D.
(4/2017, Original articles & case reports ) - Ziprasidone in the treatment of manic and mixed episodes of mild to moderate severity in patients with bipolar or schizoaffective disorder
MUDr. Dalibor Janoška, MUDr. Jozef Vido, MUDr. Petra Hermanová
(S1/2011, Original articles & case reports )
- Glatiramer acetate: long-term immunomodulatory therapy in multiple sclerosis – safety, efficacy, adherence and persistence assesment
MUDr. Olga Zapletalová
(2/2016, Review articles ) - Pharmacological profile of pregabaline (Lyrica)
doc. MUDr. Edvard Ehler, CSc.
(6/2014, Pharmacotherapy ) - Neurologické projevy poruch metabolizmu lipidů
doc. MUDr. Ivanka Vlachová
(1/2005, Main topic ) - Late Lyme neuroborreliosis or post-Lyme borreliosis syndrome? A case report
MUDr. Ladislav Gurčík, PhD.
(6/2010, Case reports ) - The concept of mild cognitive impairment in Alzheimer’s disease and Parkinson’s disease
doc. MUDr. Irena Rektorová, Ph.D.
(6/2010, Review articles ) - KLINICKÉ APLIKACE MR SPEKTROSKOPIE U PACIENTŮ S EPILEPSIÍ
MUDr. Dagmar Fojtíková
(3/2007, Review articles )
- Risk factors of atherosclerosis in childhood
MUDr. Pavol Šimurka, PhD.
(5/2010, Review articles )
- Therapy of prostate cancer in elderly patients
MUDr. Otakar Čapoun, Ph.D., FEBU
(3/2022, Review articles ) - TESTOSTERONE SUPPLEMENTATION THERAPY IN TESTICULAR CANCER PATIENTS
prof. MUDr. Dalibor Ondruš, DrSc., RNDr. Martina Ondrušová, PhD.
(1/2008, Review articles )
- Effective treatment of lung adenocarcinoma with target therapy – case report
MUDr. Gabriela Chowaniecová
(5/2017, Original articles & case reports )
- Safe and effective antihypertensive therapy in obesity
PharmDr. Iva Prokopová, Ph.D.
(4/2016, Clinical pharmacy ) - Rilmenidine use in clinical practice
MUDr. Martin Čaprnda, PhD.
(1/2014, Clinical pharmacy ) - Profile of the patient treated with antipsychotic drugs with risk factors for cardiovascular system disorders
Mgr. Slavomila Hričáková, Doc. MUDr. Tatiana Stankovičová, CSc.
(3/2017, Current pharmacotherapy )
- XXII. SLOVENSKÝ ANGIOLOGICKÝ KONGRES s medzinárodnou účasťou
(S3/2014, Supplement )